Danaher

Open: 239.19 Close: 241.71 Change: 2.52

Don't invest before reading what an AI found about Danaher Company Inc Stock.

The game is changing. There is a new strategy to evaluate Danaher fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Danaher are: Danaher, stock, year, revenue, price, Danahers, market, and the …

Concept Map

Semantic Network

Stock Summary

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization.

Today's Summary

Stock price of Danaher Corp has seen a 10% rise over the last twenty-one trading days. SVB Securities cited a range of reasons to own Danaher, including its profitability profile with gross margins around 60% or more.

Today's News

Equity research firm recommends clients buy Danaher and own the beaten-down Club stock for the long term. SVB Securities cited a range of reasons to own Danaher, including its profitability profile with gross margins around 60% or more, and ample dry powder to pursue a beneficial acquisition. Danaher Corporation is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Pomerantz LLP is investigating claims on behalf of investors of Danaher Corp. Stock price of Danaher Corp has seen a 10% rise over the last twenty-one trading days. Danahers stock price is up over 43% since the beginning of this year, outperforming the broader markets. Wall Street is expecting higher profit for Danaher when the company reports its second quarter. Danaher has made 3 investments. Their latest portfolio exit was Danaher - ForteBio & SoloHill on October 21, 2019. Danaher recently partnered with University of Pennsylvania for cell therapies. Danaher Corp. stock rises wed Wednesday, outperforms market - marketwatch.com danaher.com +2.19% SPX -0.03% DJIA - 0.14% Shares of Danaher sells off - im buying. Dividend Yield 0.3%   0.4%     Industry average for laboratory apparatus and analytical, optical, measuring, and controlling instruments stocks listed on the NYSE. Implied growth ratio within 15% range of industry average. Price / Book ratio less than industry average for lab equipment and measuring. Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The overall consensus recommendation for Danaher is Buy. For Danaher profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Danaher to generate income relative to revenue, assets, operating costs, and current equity. The profitability module also shows relationships between Danahers most relevant fundamental drivers. Profitability is the general direction of Danahers change in net profit over the period of time. Danaher is currently under evaluation in working capital category among related companies. Danaher investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. You can analyze the entity against its peers and the financial market as a whole. On this news, Danahers stock price fell $22.36 per share, or 8.79%, to close at $231.99 per share on April 25, 2023. Danaher: Q1 Earnings Snapshot. Danaher reported last year Gross Profit of 18.95 Billion. Danaher Gross Profit is relatively stable at the moment as compared to the past year. Companies with high Cash per Share ratio will be considered as an attractive investment. The proper pronunciation of the word is? a-nuhl-jee-zuhks a- nuhzuh-ks an-an-anesthetic analgesics. It is a Celtic surname. DHR stock has gained 54% since 2019 primarily due to favorable change in revenues. In 2022, Danahers revenue was $31.47 billion, an increase of 6.85% compared to the previous years $29.45 billion. Danaher shareholders are in an unfamiliar position to start 2023 given that stock in the healthcare- industrial conglomerate is underperforming the market. One Wall Street analyst says that represents an opportunity. Danaher Corporation (DHR) stock price fell $22.36 per share, or 8.79%, to close at $231.99 per share on April 25, 2023. Danaher Corp. currently has the 86th highest Short-Term Technical score in the Diagnostics & Research industry. Danaher reported on Tuesday a 7 percent year -over-year decrease in total revenues. Cepheid saw more than 30 percent core revenue growth year over year in non-respiratory testing and more than 50 percent growth in infectious disease testing. Danaher expects to perform about 30 million respiratory tests and garner $1.2 billion in revenue for full-year 2023. Wall Street analysts forecast DHR stock price to rise over the next 12 months. During the last12 months insiders bought 24.8k USD ,and sold 27.9M USD worth of shares. Anthony Seldon on Boris Johnson: ‘At his heart, he is extraordinarily empty’

Stock Profile

"Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia."

Keywords

This document will help you to evaluate Danaher without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Danaher are: Danaher, stock, year, revenue, price, Danahers, market, and the most common words in the summary are: danaher, stock, price, market, dhr, share, earnings, . One of the sentences in the summary was: Stock price of Danaher Corp has seen a 10% rise over the last twenty-one trading days. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #danaher #stock #price #market #dhr #share #earnings.